AzTrials
AzTrials

Carious TeethNCT05500547

Clinical Performance of One-shade Universal Dental Resin Composite as Posterior Restoration

A study testing US Public Health Service "USPSH" criteria for assessment of success of resin composite restorations in people with Carious Teeth, run by Minia University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is aimed to evaluate the clinical performance of new One-shade universal composite resin as posterior restoration using US Public Health Service "USPSH" criteria for color match, marginal adaptation, surface texture, retention, recurrent caries and others after 1, 3, 6 and 9 months. Read more about this study

Who is it for?
Ages 25 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Carious Teeth
What is being tested?
US Public Health Service "USPSH" criteria for assessment of success of resin composite restorations
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
15 Jul 2021to 15 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • • They should have an acceptable oral hygiene level.
  • Presence of at least two occlusal carious lesions to be restored with two different types of composite.
  • The two studied materials restorations should be used in approximately the same sized lesions or within the same extension.
  • Age range between 25 and 45years.

Who cannot join

  • • Severe or active periodontal or carious disease and heavy bruxism or a traumatic occlusion
  • Patients with a compromised medical history, or had received therapeutic irradiation to the head and neck region.
  • Alcoholic and smoker patients.
  • Patients had participated in a clinical trial within 6 months before commencement of this trial.
  • Patients unable to return for recall appointment

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ruba Salah Anwar

    Minya, 61511

Other trials in Egypt

About this study

This study is aimed to evaluate the clinical performance of new One-shade universal composite resin as posterior restoration using US Public Health Service "USPSH" criteria for color match, marginal adaptation, surface texture, retention, recurrent caries and others after 1, 3, 6 and 9 months.

Read the detailed description

One operator will place all restorations under rubber-dam isolation. The patients will receive restorations with both materials, randomly after shade selection (The shade of single shade universal resin composite "Omnichroma" will be taken before and after placement into the cavity). During the referred period, only the two composites in study will be placed in posterior teeth in the dental office. The various materials' application procedure will be applied according to manufacturer's instructions.

Conditions
Carious Teeth
Being tested
US Public Health Service "USPSH" criteria for assessment of success of resin composite restorations
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • US Public Health Service "USPSH" criteria for assessment of success of resin composite restorationsOther

    Also called assessment of Universal single shade resin composite and Nano-hybrid multi-shade resin composite restorative material using the US Public Health Service "USPSH" criteria

    US Public Health Service "USPSH" criteria for color match, marginal adaptation, surface texture, retention, recurrent caries and others after 1, 3, 6 and 9 months.

Study groups in NCT05500547
Study groupRoleWhat they receive
Universal single shade resin composite restorative materialExperimentalDental restorative material
Receives: Other: US Public Health Service "USPSH" criteria for assessment of success of resin composite restorations
Nano-hybrid multi-shade resin composite restorative materialActive comparatorDental restorative material
Receives: Other: US Public Health Service "USPSH" criteria for assessment of success of resin composite restorations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. USPSH criteria

    Alpha and Beta are clinically successful, Charlie and Delta are clinically failure

    Measured: For 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2022
  2. Study start15 Jul 2021
  3. Primary completion15 Jul 2022
  4. Study completion15 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05500547
Sponsor's protocol ID
RSAnwar
Status last verified
Aug 2022
First submitted
26 Jul 2022
Last updated
15 Aug 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing US Public Health Service "USPSH" criteria for assessment of success of resin composite restorations in people with Carious Teeth, run by Minia University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

USPSH criteria (time frame: For 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in